A case of diagnostics of IgG4-related disease with primary renal damage and secondary arterial hypertension
- Authors: Vladimirova N.N.1, Myasnikova E.V.1, Beketova T.V.1, Peredelkina A.I.1, Shunaev V.M.1, Pikunova I.N.1
-
Affiliations:
- Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian Federation
- Issue: Vol 8, No 1 (2022)
- Pages: 102-109
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288766
- DOI: https://doi.org/10.18565/therapy.2022.1.102-109
- ID: 288766
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
Nadezhda N. Vladimirova
Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian Federation
Email: glavchp@cchp.ru
PhD., cardiologist, Deputy chief physician for therapy Moscow
Elena V. Myasnikova
Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian Federation
Email: dr.myasnikova@mail.ru
therapist, head of the Department of Therapy No. 2 Moscow
Tatyana V. Beketova
Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian FederationMD, rheumatologist, head of the Department of rheumatology Moscow
Anna I. Peredelkina
Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian Federation
Email: anik_lederep@bk.ru
cardiologist Moscow
Valentin M. Shunaev
Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian Federationtherapist Moscow
Irina N. Pikunova
Central Clinical Hospital with Polyclinic of the Administration of the President of the Russian Federationtherapist Moscow
References
- Зыкова А.С., Новиков П.И., Бровко М.Ю. с соавт. IgG4-ассоциированное заболевание: что изменилось к 2020 году. Клиническая фармакология и терапия. 2020; 3: 4-13
- Maritati F., Peyronel F., Vaglio A. IgG4-related disease: A clinical perspective. Rheumatology (Oxford). 2020; 59(Suppl 3): iii123-iii131. https://dx.doi.org/10.1093/rheumatology/kez667.
- Zhang W., Stone J.H. Management of IgG4-related disease. Lancet Rheumatol. 2019; 1(1): E55-E65. https://dx.doi.org/10.1016/S2665-9913(19)30017-7.
- Kamisawa T., Funata N., Hayashi Y. et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10): 982-84. https://dx.doi.org/10.1007/s00535-003-1175-y.
- Stone J.H., Khosroshahi A., Deshpande V. et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012; 64(10): 3061-67. https://dx.doi.org/10.1002/art.34593.
- Wallace Z.S., Zhang Y., Perugino C.A. et al. Clinical phenotypes of IgG4-related disease: An analysis of two international cross sectional cohorts. Ann Rheum Dis. 2019; 78(3): 406-12. https://dx.doi.org/10.1136/annrheumdis-2018-214603.
- Wang M., Zhang P., Lin W. et al. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: Clinical manifestations and treatment efficacy. Arthritis Res Ther. 2019; 21(1): 44. https://dx.doi.org/10.1186/s13075-019-1828-8.
- Khosroshahi A., Wallace Z.S., Crowe J.L. et al. Second International Symposium on IgG4-Related Disease.International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015; 67(7): 1688-99. https://dx.doi.org/10.1002/art.39132.
- Wu Q., Chang J., Chen H. et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: A preliminary randomized controlled trial.Int J Rheum Dis. 2017; 20(5): 639-46. https://dx.doi.org/10.1111/1756-185X.13088.
- Wang L., Zhang P., Wang M. et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: A prospective study of 215 patients. Arthritis Res Ther. 2018; 20(1): 65. https://dx.doi.org/10.1186/s13075-018-1567-2.
Supplementary files
